Skip to main content
OpenTrials
Completed

NCT Number: NCT03184857

Open Maxillary Sinus Augmentation Using Different Types of Bone Particles

Two stage sinus lifting using Nano hydroxyapatite particles [Nanostreams] versus Deprotenized bovine bone [Tutogen] : Randomized clinical trial.

comparing between Height of new bone formation, Bone area percent( Histomorphometric)

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Mahmoud Ahmed Nour Eldeen

Cairo, 11437, Egypt

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

-

Exclusion criteria

  • sinus pathology
  • heavy smokers
  • patients with systemic disease uncontrolled

Treatment and study plan

open maxillary sinus lifting

Procedure

biopsy of the region 6 months later

Primary outcomes

  1. histomorphometric analysis

    Time frame: 6 months

    histomorphometric analysis to measure new bone percent formation and residual bone graft percent

Secondary outcomes

  1. new height of bone gained

    Time frame: 6 months

    CBCT 6 months postoperative to measure the new height of bone

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Two Stage Sinus Lifting Using Nano Hydroxyapatite Particles [Nanostreams] Versus Deprotenized Bovine Bone [Tutogen] : Randomized Clinical Trial.

Important dates

Study start
2017
Primary completion
2019
Study completion
2019
First posted
Jun 14, 2017
Registry last updated
Apr 2, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.